BNP Paribas Exane ranks #1 for Industry Research in Europe in the Institutional Investor survey

September 9, 2022

We are delighted to announce that today’s Institutional Investor 2022 Survey Results named BNP ParibasExane:

#1 Industry Research

#1 Sales

#1 Specialist Sales

#1 Trading

#2 Corporate Access

Within Industry Research, we ranked #1 in 14 Research categories and ranked Top 3 in 25 categories. BNP ParibasExane has once again confirmed its leading Cash Equities position, being at the top of the rankings for the 6th consecutive year.

Many thanks to all our clients for their continued and valued support.